HAE · Haemonetics Corp
$108.32
-0.08 (-0.07%)
At close · Aug 25
Market Cap
$4.95B
Shares
45.50M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-18 | — | |
| 8-K | 2026-08-06 | — | |
| 10-Q | 2026-08-06 | 2026-06-27 | |
| 8-K | 2026-07-28 | 2026-07-24 | |
| DEF 14A | 2026-06-09 | 2026-03-28 | |
| 8-K | 2026-06-05 | — | |
| 10-K | 2026-05-20 | 2026-03-28 | |
| 8-K | 2026-05-07 | — | |
| 8-K | 2026-05-01 | 2026-04-27 | |
| 8-K | 2026-03-03 | — | |
| 8-K | 2026-02-12 | — | |
| 10-Q | 2026-02-05 | 2025-12-27 | |
| 8-K | 2026-02-05 | — | |
| 8-K | 2026-01-09 | — | |
| 10-Q | 2025-11-06 | 2025-09-27 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-28 | |
| 8-K | 2025-07-25 | 2025-07-24 | |
| DEF 14A | 2025-06-06 | 2025-03-29 | |
| 10-K | 2025-05-21 | 2025-03-29 | |
| 8-K | 2025-05-08 | 2025-05-06 | |
| 8-K | 2025-03-03 | — | |
| 8-K | 2025-02-06 | — | |
| 10-Q | 2025-02-06 | 2024-12-28 | |
| 8-K | 2025-01-14 | — | |
| 8-K | 2025-01-03 | 2024-12-27 | |
| 8-K | 2024-12-03 | — | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-28 | |
| 8-K | 2024-09-16 | 2024-09-10 | |
| 10-Q | 2024-08-08 | 2024-06-29 | |
| 8-K | 2024-08-08 | — | |
| 8-K/A | 2024-07-30 | 2024-07-25 | |
| 8-K | 2024-07-25 | — | |
| DEF 14A | 2024-06-07 | 2024-03-30 | |
| 8-K | 2024-05-29 | 2024-05-22 | |
| 8-K | 2024-05-23 | 2024-05-22 | |
| 8-K | 2024-05-21 | — | |
| 10-K | 2024-05-20 | 2024-03-30 | |
| 8-K | 2024-05-09 | — | |
| 8-K | 2024-05-01 | 2024-04-30 | |
| 8-K | 2024-04-01 | — | |
| 8-K | 2024-03-05 | — | |
| 10-Q | 2024-02-08 | 2023-12-30 | |
| 8-K | 2024-02-08 | — | |
| 8-K | 2023-12-12 | — | |
| 10-Q | 2023-11-02 | 2023-09-30 | |
| 8-K | 2023-11-02 | — | |
| 8-K/A | 2023-10-12 | 2023-10-10 |
Showing 1–50 of 113 filings
Key facts
CIK
313143
CUSIP
405024100
13F (30d)
274 filings
272 filers
Visit website
Investor relations